Medical Oncologist
Clinical Trials & Access Programs
What Happens After — a Clinical Trial Ends?
The question most families ask is whether they were on a placebo for nothing, or whether they will lose access to a drug that is helping. Both are answerable. A trial ends on a planned date, not because something went wrong — and your team's job does not end when the trial does.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- You will be told what you received — The trial is unblinded at the end. Your team tells you whether you had the study drug, a comparator, or a placebo.
- Placebo-only arms are rare in cancer trials — Most cancer trials compare the new treatment against the current standard of care, not an inactive pill.
- Continued access is often possible — If the study drug is helping you, your team can apply for a compassionate-use programme before the trial closes.
- Follow-up does not stop — Monitoring continues for months or years after treatment ends. Your team stays involved in your care.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
When a clinical trial ends, your care does not stop. You will be told whether you received the study drug, a comparator, or a placebo. If the trial drug is helping you, your team will look at ways to continue access — through an extension study, a compassionate-use programme, or standard prescribing.
What happens, step by step, after a clinical trial closes?
The trial closes
The sponsor sets an end date and no new changes to your treatment are made. Data is prepared for analysis. This does not mean your cancer is no longer being monitored.
You are unblinded
Your team tells you what you actually received during the trial — the study drug, a comparator treatment, or in some cases a placebo. This usually happens at or before your first follow-up visit.
Your response is assessed
Scans or blood tests show how your cancer has behaved. What matters here is the result, not just what you received. That result shapes what your team recommends next.
Continued access is explored
If you were on the study drug and it is helping, your oncologist will look at whether a compassionate-use programme, an extension study, or standard prescribing can continue it. Raise this before the trial closes — it takes time to arrange.
Long-term follow-up begins
Trial participants are monitored for months or years after the treatment phase ends. These appointments are part of the study and usually cost you nothing extra.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What should you ask your team before the trial ends?
- When will I be told what treatment I actually received?
- If the study drug is working, what are the options to continue it?
- Is a compassionate-use or continued-access programme being planned?
- Who is my main contact once the trial team hands over my care?
- How long will follow-up appointments continue, and who covers the cost?
- What will change about my monitoring schedule after the trial ends?
Did you know?
In most cancer trials registered in India, participants in the control arm receive the current best available treatment — not an inactive placebo. An inactive placebo-only arm is permitted only where no standard treatment exists for that cancer, a condition enforced by ICMR and CDSCO ethical guidelines.
If you were in a cancer trial, the most likely scenario is that you received either the study drug or a treatment already used for your cancer.
Source: ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants; CDSCO Schedule Y
Explore 52 more Cost, Access, Trials & Choosing a Hospital topics
Clinical Trials & Access Programs
- Basket and Umbrella Trials: The New Way Trials Are Designed
- Eligibility Criteria: Why Patients Get Rejected From Trials
- How to Find Cancer Clinical Trials in India
- Phase 1, 2 and 3 Trials: What the Numbers Mean for You
- Risks, Consent and Your Right to Withdraw
- What Happens After a Trial Ends?
- What Is a Clinical Trial and Should You Join One?
- Who Pays for Treatment in a Clinical Trial?
- Will I Get a Placebo Instead of Real Treatment?
Cost, Insurance & Access in India
- Are Generic Targeted Therapy Drugs Safe and Effective?
- Biosimilars for Trastuzumab, Bevacizumab and Rituximab in India
- CGHS, ECHS, ESI and State Schemes for Cancer Drugs
- Can You Get Targeted Therapy in a Government Hospital?
- Compassionate Access and Expanded Access Programs Explained
- Cost of NGS Testing vs the Cost of Treating Blindly
- Cost of Targeted Therapy in India: Monthly Price Guide by Drug Class
- Does Ayushman Bharat Cover Targeted Therapy?
- Hidden Costs Nobody Warns You About in Cancer Treatment
- How to File a Cancer Treatment Insurance Claim Without Rejection
- How to Talk to Your Doctor About Affording Treatment
- Importing a Cancer Drug Not Available in India
- NGOs and Crowdfunding for Cancer Treatment in India
- Patient Assistance Programs for Targeted Therapy Drugs in India
- Section 80DDB and Tax Deductions for Cancer Treatment
- Total Cost of Care: Targeted Therapy vs Chemotherapy Compared
- What Happens If You Have to Stop Treatment Because of Cost?
- Will Health Insurance Pay for Oral Cancer Tablets Taken at Home?
Hospital Choice, Second Opinion & Decision Pages
- A Guide for International and NRI Patients Seeking Cancer Care in India
- Day Care Infusion Centres: What to Expect on Infusion Day
- Documents to Bring to Your First Oncology Consultation
- Follow-Up on Oral Targeted Therapy: In Person or Teleconsult?
- Getting a Second Opinion on Your Targeted Therapy Plan
- How a Molecular Tumour Board Reviews Your Case
- How to Choose a Hospital for Targeted Therapy in India
- Medical Oncologist vs Precision Oncology Specialist: Who Do You Need?
- Online and Teleconsultation Second Opinions: How They Work
- Red Flags: Signs Your Cancer Care May Not Be Up to Standard
- Transferring Your Care to Another Hospital Mid-Treatment
- What a Good Second Opinion Actually Checks: A 10-Point Audit
- What a Precision Oncology Program Should Include: A Checklist
- What to Ask Before Committing to a Cancer Treatment Plan
Work, Travel, Legal & Insurance Rights
- Buying Life or Health Insurance After a Cancer Diagnosis
- Can You Keep Working Full Time on Targeted Therapy?
- Disability Certificate for Cancer Patients in India: How to Apply
- Flying With Cancer: Fitness to Fly and Airline Rules
- Making a Will and Organising Documents During Serious Illness
- Managing Fatigue and Meetings: Practical Workday Strategies
- Planning a Holiday Around Your Treatment Schedule
- Returning to Work After a Treatment Break
- Should You Tell Your Employer About Your Cancer Diagnosis?
- Sick Leave and Employment Rights for Cancer Patients in India
- Travel Insurance When You Have Cancer
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Was I on a placebo the whole time?
You will be told exactly what you received when the trial is unblinded, which happens at or near the end of treatment. In most cancer trials in India, there is no placebo-only arm — the comparator is the current standard treatment. ICMR and CDSCO guidelines require that every participant receives at least the best available care. If a placebo arm did exist in your trial, your oncologist will explain this at unblinding and discuss your options from that point.
Will I lose access to the study drug when the trial ends?
Not automatically. When a trial drug is showing benefit, the sponsor often runs a compassionate-use or expanded-access programme so that responding participants can continue while the drug awaits regulatory approval. Your oncologist can apply on your behalf. Raise this question before the trial closes, not after — it takes time to arrange, and early notice gives your team the best chance of securing continued access for you.
How much will the treatment cost after the trial?
During the trial, the study drug is usually provided at no cost by the sponsor. What happens after depends on whether the drug has received approval and how it is covered under available schemes. Costs can be substantial. Ask your oncologist about compassionate-use programmes, which often continue to supply the drug at no charge, and about any patient-assistance scheme the manufacturer offers. Any figure you are quoted is indicative — confirm current pricing directly with your team.
Will my oncologist still see me after the trial ends?
Yes. Follow-up appointments are a formal part of the trial protocol and continue for months or years, depending on the study design. These are usually held at the same centre and at no additional cost to you during the trial period. After the formal follow-up ends, your care moves to standard outpatient appointments, which continue as long as they are clinically needed.
What if my cancer got worse while I was in the trial?
Disease progression during a trial is not a failure on your part, and it does not mean you have run out of options. Your oncologist will review what treatments are available based on where your cancer is now and what you have already received. Being in a trial means your team already has detailed, current information about your cancer — which is a starting point for the next conversation, not a closed door.